Unknown

Dataset Information

Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.


ABSTRACT:

Objective

Oral anticoagulation (OAC) prescribed to AF patients for the prevention of cardioembolic complications likely has the added benefit of preventing venous thromboembolism (VTE). This study evaluated, among AF patients who are anticoagulated, whether type of OAC was associated with subsequent VTE risk.

Methods

Non-valvular AF patients prescribed OACs between 2010 and September 2015 were identified via the MarketScan administrative claims databases. OACs included warfarin and direct OACs (DOACs: dabigatran, rivaroxaban, and apixaban). Incident VTE was defined by ICD-9-CM codes. Patients were matched on age, sex, CHA2DS2-VASc, and high-dimensional propensity scores. The final analysis included 117,912 AF patients.

Results

In total, 1357 VTE

SUBMITTER: Lutsey PL 

PROVIDER: S-EPMC6449182 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature